Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial.

We prospectively studied the impact of an antibiotic prophylaxis regimen on the incidence of infections, organ dysfunctions, and mortality in a predominantly surgical and trauma intensive care unit (ICU) population. A total of 546 patients were enrolled and stratified according to Acute Physiology and Chronic Health Evaluation (APACHE)-II scores. They were then randomized to receive either 2 x 400 mg of intravenous ciprofloxacin for 4 days, together with a mixture of topical gentamicin and polymyxin applied to the nostrils, mouth, and stomach throughout their ICU stay or to receive intravenous and topical placebo. When receiving prophylaxis, significantly fewer patients acquired infections (p = 0.001, risk ratio [RR], 0.477; 95% confidence interval [CI], 0.367-0.620), especially pneumonias (6 versus 29, p = 0.007), other lower respiratory tract infections (39 versus 70, p = 0.007), bloodstream infections (14 versus 36, p = 0.007), or urinary tract infections (36 versus 60, p = 0.042). Also, significantly fewer patients acquired severe organ dysfunctions (63 versus 96 patients, p = 0.0051; RR, 0.636; 95% CI, 0.463-0.874), especially renal dysfunctions (17 versus 38; p = 0.018). Within 5 days after admission, 24 patients died in each group, whereas 28 patients receiving prophylaxis and 51 receiving placebo died in the ICU thereafter (p = 0.0589; RR, 0.640; 95% CI, 0.402-1.017). The overall ICU mortality was not statistically different (52 versus 75 fatalities), but the mortality was significantly reduced for 237 patients of the midrange stratum with APACHE-II scores of 20-29 on admission (20 versus 38 fatalities, p = 0.0147; RR, 0.508; 95% CI, 0.295-0.875); there was still a favorable trend after 1 year (51 versus 60 fatalities; p = 0.0844; RR, 0.720; 95% CI, 0.496-1.046). Surveillance cultures from tracheobronchial, oropharyngeal, and gastric secretions and from rectal swabs did not show any evidence for the selection of resistant microorganisms in the patients receiving prophylaxis.

[1]  C. Bryan,et al.  Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. , 2015, The American review of respiratory disease.

[2]  F. V. van Tiel,et al.  Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. , 2001, American journal of respiratory and critical care medicine.

[3]  F. V. van Tiel,et al.  Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. , 2001, JAMA.

[4]  A. Corrado,et al.  Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials , 2000, BMJ : British Medical Journal.

[5]  F. Daschner,et al.  Bacterial Resistance and Overgrowth due to Selective Decontamination of the Digestive Tract , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[6]  K. Unertl,et al.  Elimination of Fecal Enterobacteriaceae by Intravenous Ciprofloxacin Is not Inhibited by Concomitant Sucralfate – a Microbiological and Pharmacokinetic Study in Patients , 1999, Infection.

[7]  T. Mort,et al.  The relationship of pre mortem diagnoses and post mortem findings in a surgical intensive care unit. , 1999, Critical care medicine.

[8]  J. Marshall,et al.  Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. , 1999, Archives of surgery.

[9]  Gordon Guyatt,et al.  Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients , 1998, Annals of Internal Medicine.

[10]  M. García,et al.  Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. , 1998 .

[11]  A. Ambergen,et al.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. , 1998, Archives of internal medicine.

[12]  V Torri,et al.  Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials , 1998, BMJ.

[13]  G. Guyatt,et al.  A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. , 1998, The New England journal of medicine.

[14]  M. Rué,et al.  Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. , 1997, Critical care medicine.

[15]  K. Unertl,et al.  Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate , 1997, Antimicrobial agents and chemotherapy.

[16]  F. Alvarez-lerma,et al.  Aetiology and diagnostic techniques in intensive care-acquired pneumonia: a Spanish multi-centre study , 1997 .

[17]  J. de Batlle,et al.  Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. , 1997, American journal of respiratory and critical care medicine.

[18]  M. Schumacher,et al.  An analysis of two prevalence surveys of nosocomial infection in German intensive care units. , 1997, The Journal of hospital infection.

[19]  A. Vuagnat,et al.  Nosocomial pneumonia and mortality among patients in intensive care units. , 1997, JAMA.

[20]  F Doyon,et al.  Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. , 1996, American journal of respiratory and critical care medicine.

[21]  A. Vuagnat,et al.  Nosocomial pneumonia and mortality among patients in intensive care units , 1996 .

[22]  R. Auckenthaler,et al.  Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. , 1996, American journal of respiratory and critical care medicine.

[23]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[24]  R. Wunderink,et al.  Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. , 1994, Chest.

[25]  Didier Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[26]  K. Kivistö,et al.  Effect of sucralfate on absorption of norfloxacin and ofloxacin , 1994, Antimicrobial Agents and Chemotherapy.

[27]  S. Lemeshow,et al.  Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. , 1993, JAMA.

[28]  P. Montravers,et al.  Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. , 1993, The American journal of medicine.

[29]  A. Localio,et al.  A predictive risk index for nosocomial pneumonia in the intensive care unit. , 1992, The American journal of medicine.

[30]  S. Chevret,et al.  A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. , 1992, The New England journal of medicine.

[31]  R. Wunderink,et al.  The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. , 1992, Chest.

[32]  M. Fox,et al.  Selective decontamination of the digestive tract in cardiac surgical patients , 1991, Critical care medicine.

[33]  M. Simberkoff,et al.  Excess mortality in critically ill patients with nosocomial bloodstream infections. , 1991, Chest.

[34]  J. Garrelts,et al.  Sucralfate significantly reduces ciprofloxacin concentrations in serum , 1990, Antimicrobial Agents and Chemotherapy.

[35]  F Lemaire,et al.  Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. , 1989, Annals of internal medicine.

[36]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[37]  J F Murray,et al.  An expanded definition of the adult respiratory distress syndrome. , 1988, The American review of respiratory disease.

[38]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[39]  M A Barry,et al.  Nosocomial infection and fatality in medical and surgical intensive care unit patients. , 1988, Archives of internal medicine.

[40]  J. Marshall,et al.  The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. , 1988, Archives of surgery.

[41]  D. Zandstra,et al.  The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. , 1987, The Journal of trauma.

[42]  J. Marshall,et al.  Multiple-organ-failure syndrome. , 1986, Archives of surgery.

[43]  E. Draper,et al.  Prognosis in Acute Organ‐System Failure , 1985, Annals of surgery.

[44]  R. Goris,et al.  Multiple-organ failure. Generalized autodestructive inflammation? , 1985, Archives of surgery.

[45]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[46]  L. Hudson,et al.  Causes of Mortality in Patients with the Adult Respiratory Distress Syndrome , 1985, The American review of respiratory disease.

[47]  C. Craig,et al.  Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. , 1984, American journal of infection control.

[48]  D. Cullen,et al.  Therapeutic Intervention Scoring System: Update 1983 , 1983, Critical care medicine.

[49]  J W Hoyt,et al.  High risk of hospital‐acquired infection in the ICU patient , 1982, Critical care medicine.

[50]  R. Penn,et al.  Colonization of the oropharynx with gram-negative bacilli: A major antecedent to nosocomial pneumonia , 1981 .

[51]  B. Rosner,et al.  Adverse effects of nosocomial infection. , 1979, The Journal of infectious diseases.

[52]  D. Cullen,et al.  Therapeutic intervention scoring system: a method for quantitative comparison of patient care. , 1974 .

[53]  J. Civetta,et al.  Therapeutic intervention scoring system: a method for quantitative comparison of patient care , 1974, Critical care medicine.

[54]  G. D. Thomas,et al.  Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. , 1972, Annals of internal medicine.

[55]  W. L. Wang,et al.  Nosocomial klebsiella infections: intestinal colonization as a reservoir. , 1971, Annals of internal medicine.

[56]  J. Sanford,et al.  Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. , 1969, The New England journal of medicine.

[57]  K. Peter,et al.  Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis , 2004, Intensive Care Medicine.

[58]  D. Zandstra,et al.  The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients , 2004, Intensive Care Medicine.

[59]  H. Kotaki,et al.  The effect of food on the interaction of ofloxacin with sucralfate in healthy volunteers , 2004, European Journal of Clinical Pharmacology.

[60]  Avid,et al.  A COMPARISON OF SUCRALFATE AND RANITIDINE FOR THE PREVENTION OF UPPER GASTROINTESTINAL BLEEDING IN PATIENTS REQUIRING MECHANICAL VENTILATION , 2001 .

[61]  G. Van den Berghe,et al.  Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. , 1997, Critical care medicine.

[62]  P. Montravers,et al.  Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. , 1993, The American review of respiratory disease.

[63]  T. Bergan,et al.  Transintestinal elimination of ciprofloxacin. , 1990, Diagnostic microbiology and infectious disease.